Ocular Therapeutix (NASDAQ:OCUL) reported its Q3 earnings results on Monday, November 8, 2021 at 04:01 PM.
Here’s what investors need to know about the announcement.
Earnings
Ocular Therapeutix their estimated earnings by 11.54%, reporting an EPS of $-0.23 versus an estimate of $-0.26, which surprised analysts.
Revenue was up $6,277,000 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.04, which was followed by a 2.42% increase in the share price the next day.
Here’s a look at Ocular Therapeutix’s past performance:
| Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.21 | -0.21 | -0.24 | |
| EPS Actual | -0.25 | -0.24 | -1.21 | -0.21 |
| Revenue Estimate | 11.60M | 7.64M | 9.76M | 5.49M |
| Revenue Actual | 11.72M | 7.34M | 7.35M | 5.88M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
